Potential role of A2A adenosine receptor in traumatic optic neuropathy - PubMed (original) (raw)
Potential role of A2A adenosine receptor in traumatic optic neuropathy
Saif Ahmad et al. J Neuroimmunol. 2013.
Abstract
In traumatic optic neuropathy (TON), apoptosis of retinal ganglion cells is closely related to the local production of reactive oxygen species and inflammatory mediators from activated microglial cells. Adenosine receptor A2A (A2AAR) has been shown to possess anti-inflammatory properties that have not been studied in TON. In the present study, we examined the role of A2AAR in retinal complications associated with TON. Initial studies in wild-type mice revealed that treatment with the A2AAR agonist resulted in marked decreases in the TON-induced microglial activation, retinal cell death and releases of reactive oxygen species and pro-inflammatory cytokines TNF-α and IL-6. To further assess the role of A2AAR in TON, we studied the effects of A2AAR ablation on the TON-induced retinal abnormalities. A2AAR-/- mice with TON showed a significantly higher mRNA level of TNF-α, Iba1-1 in retinal tissue, and ICAM-1 expression in retinal sections compared with wild-type mice with TON. To explore a potential mechanism by which A2AAR-signaling regulates inflammation in TON, we performed additional studies using hypoxia- or LPS-treated microglial cells as an in vitro model for TON. Activation of A2AAR attenuates hypoxia or LPS-induced TNF-α release and significantly repressed the inflammatory signaling, ERK in the activated microglia. Collectively, this work provides pharmacological and genetic evidence for A2AAR signaling as a control point of cell death in TON and suggests that the retinal protective effect of A2AAR is mediated by attenuating the inflammatory response that occurs in microglia via interaction with MAPKinase pathway.
Keywords: 2-p-[2-Carboxyethyl]phenethylamino-5′-N-ethylcarboxamidoadenosine; 4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol; 5′-N-Ethylcarboxamidoadenosine; AR; Adenosine A(2A) receptor; CGS21680; ELISA; ERK; Enzyme-linked immunosorbent assay; Inflammatory cytokines; LPS; MAP kinase; MAPKinase; Microglia; Mitogen-activated protein kinase; NECA; Oxidative stress; ROS; TNF-α; TON; Traumatic optic neuropathy; ZM241385; adenosine receptor; extracellular signal-regulated kinase; lipopolysaccharides; reactive oxygen species; traumatic optic neuropathy; tumor necrosis factor-α.
© 2013.
Similar articles
- Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy.
Ahmad S, Elsherbiny NM, Bhatia K, Elsherbini AM, Fulzele S, Liou GI. Ahmad S, et al. J Neuroimmunol. 2014 Dec 15;277(1-2):96-104. doi: 10.1016/j.jneuroim.2014.10.006. Epub 2014 Oct 22. J Neuroimmunol. 2014. PMID: 25457840 - Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden J, Cao Z, Murray TF. Sun WC, et al. Vet Immunol Immunopathol. 2008 Jan 15;121(1-2):91-100. doi: 10.1016/j.vetimm.2007.08.011. Epub 2007 Aug 25. Vet Immunol Immunopathol. 2008. PMID: 17913243 - The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
Zhang JG, Hepburn L, Cruz G, Borman RA, Clark KL. Zhang JG, et al. Biochem Pharmacol. 2005 Mar 15;69(6):883-9. doi: 10.1016/j.bcp.2004.12.008. Biochem Pharmacol. 2005. PMID: 15748700 - [Inhibition of stress-responsive signaling pathway prevents neural cell death following optic nerve injury].
Katome T. Katome T. Nippon Ganka Gakkai Zasshi. 2014 Nov;118(11):907-15. Nippon Ganka Gakkai Zasshi. 2014. PMID: 25543382 Review. Japanese. - Adenosine A2A agonists in development for the treatment of inflammation.
Lappas CM, Sullivan GW, Linden J. Lappas CM, et al. Expert Opin Investig Drugs. 2005 Jul;14(7):797-806. doi: 10.1517/13543784.14.7.797. Expert Opin Investig Drugs. 2005. PMID: 16022569 Review.
Cited by
- Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure.
Madeira MH, Elvas F, Boia R, Gonçalves FQ, Cunha RA, Ambrósio AF, Santiago AR. Madeira MH, et al. J Neuroinflammation. 2015 Jun 10;12:115. doi: 10.1186/s12974-015-0333-5. J Neuroinflammation. 2015. PMID: 26054642 Free PMC article. - An adherent drug depot for retinal ganglion cell protection and regeneration in rat traumatic optic neuropathy models.
Li L, Deng F, Qiu H, Li Y, Gong Z, Wang L, Wang J, Wu W, Nan K. Li L, et al. RSC Adv. 2021 Jun 28;11(37):22761-22772. doi: 10.1039/d0ra10362d. eCollection 2021 Jun 25. RSC Adv. 2021. PMID: 35480428 Free PMC article. - Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.
Krishnan A, Fei F, Jones A, Busto P, Marshak-Rothstein A, Ksander BR, Gregory-Ksander M. Krishnan A, et al. J Immunol. 2016 Dec 15;197(12):4626-4638. doi: 10.4049/jimmunol.1601488. Epub 2016 Nov 14. J Immunol. 2016. PMID: 27849168 Free PMC article. - Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
Buonfiglio F, Böhm EW, Pfeiffer N, Gericke A. Buonfiglio F, et al. Antioxidants (Basel). 2023 Jul 20;12(7):1465. doi: 10.3390/antiox12071465. Antioxidants (Basel). 2023. PMID: 37508003 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous